关注
Mahitosh Mandal
Mahitosh Mandal
Professor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, India
在 smst.iitkgp.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
A Mazumdar, RA Wang, SK Mishra, L Adam, R Bagheri-Yarmand, ...
Nature cell biology 3 (1), 30-37, 2001
4702001
Antiproliferative effects of honey and of its polyphenols: a review
SK Jaganathan, M Mandal
BioMed Research International 2009 (1), 830616, 2009
4582009
Cell cycle-dependent modulation of telomerase activity in tumor cells.
X Zhu, R Kumar, M Mandal, N Sharma, HW Sharma, U Dhingra, ...
Proceedings of the National Academy of Sciences 93 (12), 6091-6095, 1996
4201996
Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells
RK Vadlamudi, L Adam, RA Wang, M Mandal, D Nguyen, A Sahin, ...
Journal of Biological Chemistry 275 (46), 36238-36244, 2000
3172000
Regulation of cyclooxygenase-2 pathway by HER2 receptor
R Vadlamudi, M Mandal, L Adam, G Steinbach, J Mendelsohn, R Kumar
Oncogene 18 (2), 305-314, 1999
3081999
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
R Kumar, RA Wang, A Mazumdar, AH Talukder, M Mandal, Z Yang, ...
Nature 418 (6898), 654-657, 2002
2912002
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells
D Bandyopadhyay, M Mandal, L Adam, J Mendelsohn, R Kumar
Journal of Biological Chemistry 273 (3), 1568-1573, 1998
2861998
Bcl-2 modulates telomerase activity
M Mandal, R Kumar
Journal of Biological Chemistry 272 (22), 14183-14187, 1997
2831997
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer
P Venkatesan, N Puvvada, R Dash, BNP Kumar, D Sarkar, B Azab, ...
Biomaterials 32 (15), 3794-3806, 2011
2802011
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E‐cadherin down‐regulation, vimentin expression, and aggressive …
M Mandal, JN Myers, SM Lippman, FM Johnson, MD Williams, S Rayala, ...
Cancer 112 (9), 2088-2100, 2008
2492008
Autophagy: cancer’s friend or foe?
SK Bhutia, S Mukhopadhyay, N Sinha, DN Das, PK Panda, SK Patra, ...
Advances in cancer research 118, 61-95, 2013
2322013
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
R Bharti, G Dey, M Mandal
Cancer letters 375 (1), 51-61, 2016
2302016
Apoptotic effect of eugenol in human colon cancer cell lines
SK Jaganathan, A Mazumdar, D Mondhe, M Mandal
Cell biology international 35 (6), 607-615, 2011
2232011
Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1
L Adam, R Vadlamudi, M Mandal, J Chernoff, R Kumar
Journal of Biological Chemistry 275 (16), 12041-12050, 2000
2182000
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
BA Schiff, AB McMurphy, SA Jasser, MN Younes, D Doan, OG Yigitbasi, ...
Clinical cancer research 10 (24), 8594-8602, 2004
2062004
Exosome as a novel shuttle for delivery of therapeutics across biological barriers
CK Das, BC Jena, I Banerjee, S Das, A Parekh, SK Bhutia, M Mandal
Molecular pharmaceutics 16 (1), 24-40, 2018
1982018
An ethnobotanical study of traditional anti-inflammatory plants used by the Lohit community of Arunachal Pradesh, India
ND Namsa, H Tag, M Mandal, P Kalita, AK Das
Journal of ethnopharmacology 125 (2), 234-245, 2009
1982009
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
R Kumar, M Mandal, A Lipton, H Harvey, CB Thompson
Clinical cancer research: an official journal of the American Association …, 1996
1971996
Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform
H Choudhury, B Gorain, S Karmakar, E Biswas, G Dey, R Barik, M Mandal, ...
International Journal of Pharmaceutics 460 (1-2), 131-143, 2014
1942014
PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
I Pal, M Mandal
Acta Pharmacologica Sinica 33 (12), 1441-1458, 2012
1912012
系统目前无法执行此操作,请稍后再试。
文章 1–20